Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:MRK
Merck
|
130.88 | -9.8% | 3.42% | 331,493.69 | 2.34% | -19.03% |
|
LSE:AZN
AstraZeneca PLC
|
121.66 | 18.34% | 40.96% | 188,601.59 | 2.01% | 15.98% |
|
NYSE:PFE
Pfizer
|
28.92 | 7.37% | 37.31% | 163,877.87 | 5.83% | -9.31% |
|
LSE:GSK
GSK
|
17.84 | 6.89% | 22.64% | 72,731.8 | 3.2% | 0.79% |
|
ASX:CSL
CSL
|
286.95 | 19.62% | 40.06% | 138,669.37 | 1.25% | 7.18% |
|
NasdaqGS:MRNA
Moderna
|
132.68 | -,110.73% | -,107.41% | 50,848.25 | 0% | 0% |
|
NasdaqGS:BNTX
BioNTech
|
92.98 | 0% | 0% | 22,407.3 | 0% | 299.65% |
|
TWSE:4142
Adimmune
|
31.05 | 0% | 0% | 14,078.37 | 0% | -96.7% |
|
KOSDAQ:A206650
EuBiologics
|
12180.00 | 0% | 0% | 364,548.07 | 0% | 0% |
|
NYSE:EBS
Emergent BioSolutions
|
5.27 | 33.09% | 174.9% | 229 | 0% | 0% |
